• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Catalyst Pharmaceuticals, Inc. - Common Stock (NQ:CPRX)

    26.25 +0.36 (+1.39%)
    Streaming Delayed Price Updated: 11:21 AM EDT, Apr 17, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 671,553
    Open 26.20
    Bid (Size) 26.24 (1,000)
    Ask (Size) 26.26 (300)
    Prev. Close 25.89
    Today's Range 25.85 - 26.26
    52wk Range 19.05 - 26.58
    Shares Outstanding 102,780,151
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Catalyst Pharmaceuticals Inc (NASDAQ:CPRX): A Strong Growth Stock with a Positive Technical Setup ↗
    Catalyst Pharmaceuticals (CPRX) combines strong growth, high profitability, and a debt-free balance sheet with a positive technical trend, signaling a potential breakout opportunity. 
    Via Chartmill
    News headline image
    Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) Emerges as a Top Affordable Growth Stock ↗
    Catalyst Pharmaceuticals (CPRX) exemplifies affordable growth with strong earnings, a debt-free balance sheet, and a valuation below industry averages. 
    Via Chartmill

    Performance

    YTD
    +13.4%
    +13.4%
    1 Month
    +12.6%
    +12.6%
    3 Month
    +14.3%
    +14.3%
    6 Month
    +27.9%
    +27.9%
    1 Year
    +18.3%
    +18.3%

    More News

    Read More
    Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) Stands Out as a Quality Investment ↗
    Via Chartmill
    Catalyst Pharmaceuticals Inc. (NASDAQ:CPRX) Presents a Compelling Value Investment Case ↗
    Via Chartmill
    News headline image
    Catalyst Pharmaceuticals to Showcase Real‑World Findings in Duchenne Muscular Dystrophy and Host Vamorolone-Focused Symposium at the 2026 MDA Clinical & Scientific Conference
    From Catalyst Pharmaceuticals, Inc.
    Via GlobeNewswire
    Catalyst Pharmaceuticals Inc (NASDAQ:CPRX): A Strong Fundamental and Technical Setup ↗
    Via Chartmill
    Catalyst Pharmaceuticals Inc. (NASDAQ:CPRX) Shows Technical Setup for Potential Breakout ↗
    Via Chartmill
    Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) Beats Q4 Estimates, Issues Conservative 2026 Outlook ↗
    Via Chartmill
    News headline image
    Catalyst Pharmaceuticals Reports Record Fourth Quarter and Record Full Year 2025 Financial Results and Provides 2026 Financial Guidance
    From Catalyst Pharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    Catalyst Pharmaceuticals to Participate in the Barclays 28th Annual Global Healthcare Conference
    From Catalyst Pharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026
    From Catalyst Pharmaceuticals, Inc.
    Via GlobeNewswire
    Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) Combines Strong Growth with Bullish Technical Setup ↗
    Via Chartmill
    Catalyst Pharmaceuticals Inc. (NASDAQ:CPRX) Screens as an Affordable Growth Stock ↗
    Via Chartmill
    Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) Presents a Compelling Value Investment Case ↗
    Via Chartmill
    News headline image
    2 Under-the-Radar Biotech Stocks Set to Boom in 2026 ↗
    Via The Motley Fool
    Topics ETFs Intellectual Property World Trade
    Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) Combines Strong Fundamentals with a Technical Breakout Setup ↗
    Via Chartmill
    News headline image
    The University of Notre Dame and Catalyst Pharmaceuticals Host Inaugural Catalyst Advocacy Scholars Summit (CASS)
    From Catalyst Pharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    Catalyst Pharmaceuticals Executive Cashes Out 10,983 Shares -- What's Behind the Move? ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) Emerges as a Top GARP Stock Pick ↗
    Via Chartmill
    News headline image
    Catalyst Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference
    From Catalyst Pharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    Catalyst Pharmaceuticals Inc (NASDAQ:CPRX): A Strong Growth Stock with a Bullish Technical Setup ↗
    Via Chartmill
    News headline image
    Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) Passes the Caviar Cruise Quality Investing Screen ↗
    Via Chartmill
    News headline image
    Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) Represents an Affordable Growth Opportunity ↗
    Via Chartmill
    News headline image
    Catalyst Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference
    From Catalyst Pharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) Combines Strong Growth with Bullish Technical Setup ↗
    Via Chartmill

    Frequently Asked Questions

    Is Catalyst Pharmaceuticals, Inc. - Common Stock publicly traded?
    Yes, Catalyst Pharmaceuticals, Inc. - Common Stock is publicly traded.
    What exchange does Catalyst Pharmaceuticals, Inc. - Common Stock trade on?
    Catalyst Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Catalyst Pharmaceuticals, Inc. - Common Stock?
    The ticker symbol for Catalyst Pharmaceuticals, Inc. - Common Stock is CPRX on the Nasdaq Stock Market
    What is the current price of Catalyst Pharmaceuticals, Inc. - Common Stock?
    The current price of Catalyst Pharmaceuticals, Inc. - Common Stock is 26.25
    When was Catalyst Pharmaceuticals, Inc. - Common Stock last traded?
    The last trade of Catalyst Pharmaceuticals, Inc. - Common Stock was at 04/17/26 11:21 AM ET
    What is the market capitalization of Catalyst Pharmaceuticals, Inc. - Common Stock?
    The market capitalization of Catalyst Pharmaceuticals, Inc. - Common Stock is 2.70B
    How many shares of Catalyst Pharmaceuticals, Inc. - Common Stock are outstanding?
    Catalyst Pharmaceuticals, Inc. - Common Stock has 3B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.